找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy and Biomarkers in Neurodegenerative Disorders; Martin Ingelsson,Lars Lannfelt Book 2016 Springer Science+Business Media New

[復(fù)制鏈接]
查看: 55416|回復(fù): 58
樓主
發(fā)表于 2025-3-21 18:32:11 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders
編輯Martin Ingelsson,Lars Lannfelt
視頻videohttp://file.papertrans.cn/463/462299/462299.mp4
概述Includes cutting-edge techniques for the study of neurodegenerative disorders through immunotherapy and biomarker research.Offers state-of-the-art contributions from renowned experts.Features practica
叢書名稱Methods in Pharmacology and Toxicology
圖書封面Titlebook: Immunotherapy and Biomarkers in Neurodegenerative Disorders;  Martin Ingelsson,Lars Lannfelt Book 2016 Springer Science+Business Media New
描述.This practical volume examines a number of topicsthat explore the current status of immunotherapy and diagnostic markers forneurodegenerative disorders. With a focus on Alzheimer’s disease, the firstsections of the book examine immunotherapeutic approaches for theaforementioned disease as well as for Parkinson’s disease and Huntington’s disease,amongst others. The last section of the book covers the importance of biomarkertechniques to catch these diseases early enough for the treatments to be mostuseful. Written for the .Methods inPharmacology and Toxicology. series, this book contains the kind of detaileddescriptions and implementation advice that will offer a smooth transition intothe lab...Authoritative and useful, .Immunotherapy and Biomarkers inNeurodegenerative Disorders. aims to aid in the continued progress in thedevelopment of novel immune-based drugs and diagnostic tools for thesedevastating brain diseases..
出版日期Book 2016
關(guān)鍵詞Amyloid-Beta; Alzheimer’s Disease; Αlpha-Synuclein; Tau protein; Therapeutic antibodies; Monoclonal antib
版次1
doihttps://doi.org/10.1007/978-1-4939-3560-4
isbn_softcover978-1-4939-8078-9
isbn_ebook978-1-4939-3560-4Series ISSN 1557-2153 Series E-ISSN 1940-6053
issn_series 1557-2153
copyrightSpringer Science+Business Media New York 2016
The information of publication is updating

書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders影響因子(影響力)




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders影響因子(影響力)學(xué)科排名




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders網(wǎng)絡(luò)公開度




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders被引頻次




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders被引頻次學(xué)科排名




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders年度引用




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders年度引用學(xué)科排名




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders讀者反饋




書目名稱Immunotherapy and Biomarkers in Neurodegenerative Disorders讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:21:32 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:33:43 | 只看該作者
Martin Ingelsson,Lars LannfeltIncludes cutting-edge techniques for the study of neurodegenerative disorders through immunotherapy and biomarker research.Offers state-of-the-art contributions from renowned experts.Features practica
地板
發(fā)表于 2025-3-22 06:59:11 | 只看該作者
5#
發(fā)表于 2025-3-22 12:38:44 | 只看該作者
https://doi.org/10.1007/978-1-4939-3560-4Amyloid-Beta; Alzheimer’s Disease; Αlpha-Synuclein; Tau protein; Therapeutic antibodies; Monoclonal antib
6#
發(fā)表于 2025-3-22 16:15:52 | 只看該作者
7#
發(fā)表于 2025-3-22 18:38:13 | 只看該作者
8#
發(fā)表于 2025-3-22 23:26:32 | 只看該作者
9#
發(fā)表于 2025-3-23 01:28:41 | 只看該作者
10#
發(fā)表于 2025-3-23 05:45:26 | 只看該作者
PET Imaging as a Diagnostic Tool in Alzheimer’s Diseasensmitter, and neuroinflammation ligands help to understand the pathophysiology of AD, but further studies are needed to understand how they can be applied in the diagnostic process. Which combination of these biomarkers that eventually will turn out to be the most sensitive and best predictor of AD remains to be determined.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 18:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
仁寿县| 宿迁市| 乌恰县| 东乡族自治县| 双桥区| 高州市| 堆龙德庆县| 二连浩特市| 晋中市| 花莲市| 句容市| 高碑店市| 读书| 邢台市| 彭阳县| 台中市| 武定县| 长宁区| 韩城市| 龙井市| 大同市| 阳朔县| 伽师县| 中阳县| 潮州市| 福贡县| 肃宁县| 谷城县| 稻城县| 平利县| 酉阳| 嫩江县| 灌阳县| 隆安县| 遂平县| 茂名市| 公安县| 衡阳县| 凭祥市| 富源县| 玛纳斯县|